Search Results

Around 90% of cannabis farms in California are currently dealing with a serious problem: a harmful pathogen that can ruin the value of their crops, rendering them worthless. However, there is some good news on the horizon for these struggling farmers. Scientists have recently made a promising discovery involving a purple-colored strain of cannabis that seems to possess the ability to combat the widespread plant disease known as hop-latent viroid (HLVd). This disease causes damage to cannabis plants and significantly diminishes their value by reducing the production of important compounds like THC. A group of scientists from Medicinal Genomics, a company based in Massachusetts, unintentionally stumbled upon this finding when they noticed that one of their cannabis plants exhibited partial resistance to HLVd. Interestingly, they also observed that the plant turned purple as it fought off the disease. Occasionally, cannabis plants can exhibit colors other than green due to genetic or environmental factors, including shades of red, blue, and purple. Purple varieties have long been highly regarded in the cannabis community, with sought-after strains like Granddaddy Purple, Mendocino Purps, and Purple Haze. Kevin McKernan, the chief science officer at Medicinal Genomics, shared these findings at a conference in Florida, stating that the purple plant displayed a significantly stronger purple hue compared to a genetically identical plant that hadn't been exposed to the viroid. While the reason behind this phenomenon remains unknown, it is speculated to be an immune response. However, the increased purple coloring was not observed to the same extent in the control plant that was not infected with the viroid. At the same conference, Zamir K. Punja, a Canadian professor of plant biology, emphasized the severity of HLVd as a "major threat" to cannabis farms. His research has shown that infected plants can experience a 40% reduction in THC yield, resulting in significant economic losses for farmers.

Maryland has officially started selling recreational cannabis on July 1st, with around 100 authorized dispensaries catering to adult customers. These dispensaries have converted their licenses from medical to recreational sales. Adults aged 21 and above can possess limited amounts of cannabis products and purchase them from dispensaries, with a 9% sales tax applied. Maryland's move comes after more than five years of medical marijuana sales and sets it apart from neighboring states. The state aims to issue more licenses in the future, focusing on equity for minority- and women-owned businesses. The launch of recreational sales presents a significant economic opportunity and may influence cannabis policies at both state and federal levels.

Inflammatory Bowel Diseases (IBD) afflict millions of people worldwide, causing chronic inflammation and debilitating symptoms such as abdominal pain, diarrhea, nausea, and weight loss. While conventional treatments offer limited relief, a glimmer of hope emerges from the realm of medicinal cannabis as a potential alternative. Although scientific evidence is still evolving, studies and real-world experiences suggest that cannabis may provide much-needed symptom relief for those grappling with IBD. A recent survey conducted at an IBD clinic by the University of Puerto Rico School of Medicine unveiled encouraging results regarding the use of medicinal cannabis in IBD treatment. More than one-third of the 162 surveyed patients reported utilizing medical cannabis, with the majority reporting improvements in symptoms and an enhanced quality of life. In fact, a significant percentage of participants expressed their willingness to recommend cannabis to others with IBD, attesting to its perceived benefits. Supporting evidence for the effectiveness of medicinal cannabis in addressing IBD-related symptoms can also be found in earlier studies. In one notable observational study conducted in Israel, a small group of patients with Crohn's disease reported positive outcomes after incorporating medical cannabis into their treatment regimen. The majority of the participants experienced varying levels of symptom relief, providing further grounds for exploration. Despite these promising findings, it is important to acknowledge that many healthcare professionals still lack knowledge and understanding of medicinal cannabis as a treatment option for IBD. A survey of gastroenterologists revealed their limited awareness of the therapeutic benefits of cannabis, highlighting the need for further education and training in this area. Initiatives such as the Medical Cannabis Clinicians Society aim to bridge this knowledge gap by offering resources and support for healthcare professionals interested in incorporating medicinal cannabis into their practice. While the scientific community continues to explore the potential of medicinal cannabis in IBD treatment, patients and healthcare providers must navigate this emerging field with caution. It is essential to consult with medical professionals knowledgeable in cannabis therapy and to consider potential side effects and interactions with other medications. As further research unfolds, continued dialogue and collaboration between patients, healthcare providers, and researchers will be vital in harnessing the full potential of medicinal cannabis as a treatment option for Inflammatory Bowel Diseases.

Florida's Attorney General, Ashley Moody, opposes the legalization of marijuana in the state. She believes the ballot language is misleading and lacks clear information. Moody is concerned about the federal illegality of marijuana and disputes the notion of increased competition and lower prices. She also worries about the Department of Health's ability to regulate the drug adequately. If legalization proceeds and Governor Ron DeSantis runs for president, both marijuana and DeSantis could be on the ballot. The proposal allows recreational use of marijuana for adults and has support from Truelieve, but faces opposition from groups like the Florida Chamber of Commerce and the Drug Free America Foundation. DeSantis' stance on marijuana has been inconsistent despite his recent statement against its legalization.

Ukraine's President Volodymyr Zelensky has expressed support for the legalization of medical marijuana, emphasizing its potential benefits for individuals suffering from the psychological and physical tolls of the country's conflict with Russia. By acknowledging the profound impact of war-related trauma, the president believes that medical cannabis could serve as a therapeutic tool, offering relief and support to those in need. We must finally fairly legalize cannabis-based medicines for all those who need them, with appropriate scientific research and controlled Ukrainian production. - Volodymyr Zelensky With this endorsement, Ukraine joins the growing global movement recognizing the potential of medical marijuana in addressing the challenges faced by war veterans and individuals affected by conflict-induced trauma.

The NBA has officially eliminated marijuana from its list of banned substances and has opened the doors for players to invest in cannabis companies. This decision represents a notable shift in the NBA's stance on marijuana, recognizing the changing perceptions surrounding the plant. Going forward, NBA players will no longer face penalties for marijuana use, and they will have the freedom to explore investment opportunities within the thriving cannabis industry. This development reflects the broader trend of relaxing cannabis regulations and acknowledges the potential benefits and economic prospects associated with marijuana.

Canopy Growth, a cannabis company once worth billions, is now facing serious problems. Analysts believe its stock could eventually become worthless. The company's shares have been falling for two days, raising concerns about its financial situation. An analyst even lowered the price target for the stock to zero. The company's stock has dropped by 78% this year due to tough competition in the marijuana market and slow progress on US federal legalization. Its market value has significantly declined, leading to its removal from an important index. Despite trying to expand in the US, where marijuana is still federally illegal, the company's future remains uncertain. Overall, the company is facing major challenges, and analysts are doubtful about its chances of recovery.

Maryland is set to legalize recreational marijuana, a significant achievement for advocates after a lengthy process. On July 1, 2023, adults aged 21 and above will be able to possess up to 1.5 ounces of cannabis legally. The possession of up to 2.5 ounces will incur a civil penalty instead of a criminal charge. Maryland joins 19 other states and Washington, D.C. in legalizing marijuana. The journey towards legalization involved key events, including voter approval in November 2022 and the passing of legislation to establish licensing and tax rates. The path also included initiatives to train law enforcement officers in identifying marijuana impairment while driving. The new law offers expungement provisions for certain marijuana possession cases.

The American cannabis industry is projected to contribute a staggering $130 billion annually to the U.S. economy by 2024. These estimates from the Marijuana Business Factbook show a significant growth trajectory, with legal cannabis sales expected to increase from $38 billion-$46 billion in 2019 to $106 billion-$130 billion by 2024. This highlights the industry's rapid evolution and its ability to create jobs, open new business opportunities, and have a positive impact throughout the country. Despite the challenges posed by the pandemic, the cannabis industry remains strong, and its economic impact goes beyond the revenues generated within the supply chain. The industry's contribution is evident in areas such as cannabis tourism, real estate, construction, and tax revenue, supporting infrastructure projects and government programs. These findings provide valuable insights for lawmakers and officials when considering the benefits of cannabis legalization.